Latest Insider Transactions at Longeveron Inc. (LGVN)
This section provides a real-time view of insider transactions for Longeveron Inc. (LGVN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Longeveron Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Longeveron Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 13
2021
|
Rock Soffer |
BUY
Open market or private purchase
|
Direct |
12,000
+18.82%
|
$36,000
$3.76 P/Share
|
Oct 12
2021
|
Joshua Hare Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+0.03%
|
$7,500
$3.69 P/Share
|
Oct 12
2021
|
Rock Soffer |
BUY
Open market or private purchase
|
Direct |
4,000
+9.14%
|
$12,000
$3.57 P/Share
|
Oct 11
2021
|
Rock Soffer |
BUY
Open market or private purchase
|
Direct |
3,900
+9.83%
|
$11,700
$3.45 P/Share
|
Oct 08
2021
|
Joshua Hare Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
3,015
+0.04%
|
$9,045
$3.39 P/Share
|
Oct 07
2021
|
Joshua Hare Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
1,985
+0.03%
|
$5,955
$3.38 P/Share
|
Oct 07
2021
|
Paul T Lehr General Counsel, Secretary |
BUY
Open market or private purchase
|
Direct |
1,750
+1.48%
|
$5,250
$3.34 P/Share
|
Oct 07
2021
|
James Clavijo CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
5,000
+5.91%
|
$15,000
$3.34 P/Share
|
Oct 01
2021
|
Geoff Green CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,929
-24.05%
|
$131,787
$3.65 P/Share
|
Oct 01
2021
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,052
-20.34%
|
$57,156
$3.65 P/Share
|
Oct 01
2021
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
38,752
-25.27%
|
$116,256
$3.65 P/Share
|
Jul 20
2021
|
Joshua Hare Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,335
+0.16%
|
-
|
Jul 20
2021
|
Paul T Lehr General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
6,167
+3.87%
|
-
|
Jul 20
2021
|
Geoff Green CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,223
+4.31%
|
-
|
Jun 03
2021
|
Ursula Ungaro |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
May 12
2021
|
Joshua Hare Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.06%
|
-
|
May 12
2021
|
Neil E Hare |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+7.87%
|
-
|
May 12
2021
|
Donald M Soffer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+3.06%
|
-
|
May 12
2021
|
Rock Soffer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+13.57%
|
-
|
Feb 12
2021
|
Donald M Soffer |
BUY
Open market or private purchase
|
Direct |
100,000
+39.45%
|
$1,000,000
$10.0 P/Share
|
Feb 12
2021
|
Rock Soffer |
BUY
Open market or private purchase
|
Direct |
100
+0.37%
|
$800
$8.05 P/Share
|
Feb 12
2021
|
Joshua Hare Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
103,000
+0.64%
|
$927,000
$9.12 P/Share
|
Feb 11
2021
|
Erin Borger |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,000
-100.0%
|
-
|
Feb 11
2021
|
Douglas W Losordo |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
Feb 11
2021
|
Erin Borger |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
Feb 11
2021
|
Cathy Ross |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|